GECOTEND is a new medical research organization in the field of neurodegenarative diseases related some of them to aging as alzheimer diseases, parkinson huntington diseases and Amyotrophic lateral sclerosis.

Gecotend provides the complete clinical operation services for all stages of drug development. The clinical trials are developed in compliance with the best quality standards: Rigor in terms of protocol design, study conduct and results analisys.